Разработка научных основ создания технологии выделения и очистки генно-инженерных белков (1090305), страница 40
Текст из файла (страница 40)
A Double-Blind Crossover Trial inEstablished Diabetic Patients. // Lancet. 1982. V.2 (8294). P.354-357.F Fischer, B.; Sumner, I.; Goodenough, P. / Isolation, renaturation, and formation of29disulfide bonds of eukaryotic proteins expressed in Escherichia coli as inclusion bodies. //Biotechnol Bioeng. 1993. V.41(1). P.3-13.F Datar, R. V.; Cartwright, T.; Rosen, C.-G. / Process economics of animal cell and bacterial30fermentations: a case study analysis of tissue plasminogen activator // Biotechnology (N Y)1993. V.11(3). P.349-357.F Gross, G.; Hollatz, I. / Coliphage lambda to terminator lowers the stability of messenger31RNA in Escherichia coli hosts // Gene 1988.
V.72(1-2). P.119-128.F Sawers G., Jarsch M. / Alternative regulation principles for the production of recombinant32proteins in Escherichia coli // Appl Microbiol Biotechnol. 1996. V.46(1). P.1-9.F279F Gold L., Stormo G. D. / High-level translation initiation // Methods Enzymol. 1990. V.185.33P.89-93.F Gottesman S. / Minimizing proteolysis in Escherichia coli: genetic solutions // Methods34Enzymol. 1990. V.185.
P.119-129.F Nygren P.-A., Sthl S., Uhlen M. / Engineering proteins to facilitate bioprocessing // Trends35Biotechnol. 1994. V.12(5). P.184-188.F Schein C. / Solubility as a function of protein structure and solvent of protein structure and36solvent components. // Bio/Technology 1990. V.8. P.308-317/F Kane J. F., and Hartley D. L.
/ Formation of recombinant protein inclusion bodies in37Escherichia coli // Tibtech 1988. V.6. P.95-101.F Wilkinson D. L., and Harrison R. G. / Predicting the solubility ofrecombinant proteins in38Escherichia coli. // Bio/Technology 1991. V.9. P.443-448.F Gribskov M. and Burgess R. R. / Overexpression and purification of the sigma subunit of39Escherichia coli RNA polymerase. // Gene 1983. V.26. P.109-118F Kiefhaber T., Rudolph R., Kohler H.-H., and Buchner J.
/ Protein aggregation in vitro and40in viva: a quantitative model of the kinetic competition between folding and aggregation. //Bio/Technology 1991. V.9. P.825-829.F Kopetzki, E., Schumacher, C., and Bucket, P. / Control of formation of active soluble or41inactive insoluble baker’s yeast alpha-glucosidase P1 in Escherichia coli by induction andgrowth conditions. // Mol. Gen. Genet.
1989. V.216. P.149-155.F Cabilly S. / Growth at sub-optimal temperatures allows the production of functional42antigen-binding Fab fragments in Escherichia coli. // Gene 1989. V.85. P.553-557.F Fahey R. C., Hunt, J. S. and Windham, C. C. / On the cysteine and cystine content of43proteins. Differences between intracellular and extracellular proteins. // J. Mol.
Evol. 1977. V.10. P.155-163.F Rudolph R., and Fuch ,I. / Influence of glutathione on the reactivation of enzymes44containing cysteine. // Hoppe-Seyler’s Z. Physiol. Chem. 1983. V/364. P.813-820.F Derman A. I., Prinz W., Belin D., and Beckwith J. / Mutations that allow disulfide bond45formation in the cytosol of Escherichia coli.
// Science 1993. V.262. P.1744-1747.F Skerra A., and Pluckthun A. / Assembly of a functional immunoglobulin Fv fragment in46Escherichia coli. // Science 1988. V.240. P.1038-1042.F280F Pluckthun A. / Antibody engineering: Advances from the use of Escherichia coil47expression systems. // Bio/Technology 1991. V.9. P.545-551.F Carter P., Kelley R. F., Rodrigues M. L., Snedecor B., Covarrubias M., Velligan M., Wong48W. L. 1., Rowland A.
M., Kotts C. L., Carver M. E., Yang M., Bourell J. H., Shepard H. M.,and Henner D. / High level Escherichia coil expression and production of a bivalenthumanized antibody fragment. // Bio/ Technology 1992. V.10. P.163-167.F Bardwel, J. C. A., McGovem K., and Beckwith J.
/ Identification of a protein required for49disulfide bond formation in viva. // Cell 1991. V.67. P.581-589.F Missiakas D., Schwager F., and Raina S. / Identification and characterization of a new50disulfide isomerase-like protein (DsbD) in Escherichia coli. // EMBO J. 1995. V.14. P.3415-3424.F Rudolph R. / Successful protein folding on an industrial scale. In Protein Engineering:51Principles and Practices // (Cleland J. L., and Craik Ch. S., eds) John Wiley & Sons(NY) P.283-298.F Diaz-Collier J. A., Palmier M.
0., Kretzmer K. K., Bishop B. F., Comb, R. C., Obukowicz52M. C., Frazier R. B., Bild C. S., Joy W. D., Hill S. R., Duffin K. L., Gustafson M. E., JungerK. D., Grabner R. W., Galluppi C. R., and Wun T.-C. / Refolding and characterization ofrecombinant tissue factor pathway inhibitor expressed in Escherichia coli.
// Thromb.Haemostasis 1994. V.71. P.339-346.F Kuhelj R., Dolinar M., Pungerrcar J., and Turk V. / The preparation of catalytical active53human cathepsin B from its precursor expressed in Escherichia coli in the form of inclusionbodies. // Eur. J. Biochem. 1995. V.229. P.533-539.F Hejnaes K. R., Bayne S., Norskoy L., Sorensen H. H., Thomsen J., Schaffer L., Wollmer A.,54and Skriver L. / Development of an optimized refolding process for recombinant Ala-CluIGF-l. // Protein Eng. 1992. V.8. P.797-806.F Vallejo L.F., Rinas U. / Strategies for the recovery of active proteins through refolding of55bacterial inclusion body proteins // Microbial Cell Factories 2004.
V.3 P.11.F Hart R. A., Rinse U., and Bailey J. E. / Protein composition of Vitreosciiia hemoglobin56inclusion bodies produced in Escherichia coli. // J. Biol. Chem. 1990. V.265. P.12728-12733.F Valax P. and Georgiou G. / Molecular characterization of beta-lactamase inclusionbodies57produced in Escherichia coli. 1. Composition.
// Biotechnol. Prog. 1993. V.9. P.539–547.F281F Oberg K., Chrunyk A., Wetzel R.,and Fink A. / Native-like secondary structure in58interleukin-l inclusion bodies by attenuated total reflectance FTIR. // Biochemistry 1994. V.33. P.2628-2634.F Przybycien T. M., Dunn J. P., Valax, P. and Ceorgiou, C. / Secondary structure59characterization of -lactamase inclusion bodies. // Protein Eng. 1994. V.1. P.131-136.F Hagel P., Gerding J.J.T., Fieggen W., Bloemendal H. / Cyanate formation in solutions of60urea I.
Calculation of cyanate concentrations at different temperature and pH. // BiochimBiophys Acta 1971. V.243. P.366-373.F Cejka J., Vodražka Z., Salak J. / Carbamylation of globin in electrophoresis and61chromatography in the presence of urea. // Biochim Biophys Acta 1968. V.154. P.589-591.F Iwakura M., Obara K., Kokubu T., Ohashi S., Izutsu H. / Expression and purification of62growth hormone-releasing factor with the aid of dihydrofolate reductase handle.
// J Biochem(Tokyo) 1992. V.112. P57-62.F Khan R.H., Appa Rao K.B.C., Eshwari A.N.S., Totey S.M., Panda A.K. / Solubilization of63recombinant ovine growth hormone with retention of native-like secondary structure and itsrefolding from the inclusion bodies of Escherichia coli.
// Biotechnol Prog 1998. V.14. P.722-728.F Patra A.K., Mukhopadhyay R., Mukhija R., Krishnan A., Garg L.C., Panda A.K.. /64Optimization of inclusion body solubilization and renaturation of recombinant human growthhormone from Escherichia coli. // Protein Expr Purif 2000. V.18. P.182-192.F Thatcher D.R., Hitchcock A. / Protein folding in biotechnology.
In Mechanisms of protein65refolding Edited by: Pain HR. // Oxford: Oxford University Press 1994. P.229-254.F Stöckel J., Döring K., Malotka J., Jähnig F., Dornmair K.. / Pathway of detergent66mediated and peptide ligand-mediated refolding of heterodimeric class II majorhistocompatibility complex (MHC) molecules. // Eur J Biochem. 1997. V.248(3). P.684-691.F Cardamone M., Puri N.K., Brandon M.R. / Comparing the refolding and reoxidating of67recombinant porcine growth hormone from a urea denaturated state and from Escherichia coliinclusion bodies // Biochemistry 1995. V.34.
P.5773-5794.F Puri N. K. et. al. / Solubisation of growth hormone and other recombinant proteins from68Escherichia coli inclusion bodies by using a cationic surfactant // Biochem. J. 1992. V.285. P.871-879.F282F Burgess R.R. / Purification of overproduced Escherichia coli RNA polymerase sigma69factors by solubilizing inclusion bodies and refolding from sarcosyl // Methods Enzymol.1996. V.273. P.145-149.F Gierasch L.M., Lacy J.E., Thompson K.F., Rockwell A.L., Watnick P.I. / Conformations of70model peptides in membrane-mimetic environments // Biophy. J. 1982. V.37. P.275–284.F Tsumoto K., Ejima D., Kumagai I., Arakawa T. / Practical considerations in refolding71proteins from inclusion bodies // Protein Expression and Purification 2003. V2.8.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
